Childhood chronic inflammatory demyelinating polyradiculoneuropathy: Combined analysis of a large cohort and eleven published series

Neuromuscular Disorders - Tập 23 - Trang 103-111 - 2013
Hugh J. McMillan1, Peter B. Kang, H. Royden Jones2, Basil T. Darras
1Division of Neurology, Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada K1H 8L1
2Lahey Clinic, 41 Mall Road, Burlington, MA 01805, United States

Tài liệu tham khảo

Sladky, 1986, Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid-responsive disorder, Ann Neurol, 20, 76, 10.1002/ana.410200113 Nevo, 1996, Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up, Neurology, 47, 98, 10.1212/WNL.47.1.98 McLeod, 1999, Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia, Ann Neurol, 46, 910, 10.1002/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2 Koller, 2005, Chronic inflammatory demyelinating polyneuropathy, N Engl J Med, 352, 1343, 10.1056/NEJMra041347 1991, Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force, Neurology, 41, 617, 10.1212/WNL.41.5.617 Saperstein, 2001, Clinical spectrum of chronic acquired demyelinating polyneuropathies, Muscle Nerve, 24, 311, 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A Hughes, 2001, Chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 50, 281, 10.1002/ana.1142 Nevo, 2002, 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8–10, 2000, Neuromuscul Disord, 12, 195, 10.1016/S0960-8966(01)00286-3 Rossignol, 2007, Evolution and treatment of childhood chronic inflammatory polyneuropathy, Pediatr Neurol, 36, 88, 10.1016/j.pediatrneurol.2006.09.012 Ryan, 2000, Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome, Neuromuscul Disord, 10, 398, 10.1016/S0960-8966(00)00119-X Hattori, 1998, Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood, J Neurol Sci, 154, 66, 10.1016/S0022-510X(97)00216-5 Simmons, 1997, Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults, Muscle Nerve, 20, 1008, 10.1002/(SICI)1097-4598(199708)20:8<1008::AID-MUS11>3.0.CO;2-R Simmons, 1997, Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults, Muscle Nerve, 20, 1569, 10.1002/(SICI)1097-4598(199712)20:12<1569::AID-MUS12>3.0.CO;2-W Korinthenberg, 1999, Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment, Neuropediatrics, 30, 190, 10.1055/s-2007-973489 Vedanarayanan, 1991, Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin, Neurology, 41, 828, 10.1212/WNL.41.6.828 Rodriguez-Casero, 2005, Subacute inflammatory demyelinating polyneuropathy in children, Neurology, 64, 1786, 10.1212/01.WNL.0000162047.89440.B9 Uncini, 1991, Chronic inflammatory demyelinating polyneuropathy in childhood: clinical and electrophysiological features, Childs Nerv Syst, 7, 191, 10.1007/BF00249394 Colan, 1980, Steroid-responsive polyneuropathy with subacute onset in childhood, J Pediatr, 97, 374, 10.1016/S0022-3476(80)80184-3 Pitt, 2006, Maturational changes vis-à-vis neurophysiology markers and the development of peripheral nerves, 146 van Swieten, 1988, Interobserver agreement for the assessment of handicap in stroke patients, Stroke, 19, 604, 10.1161/01.STR.19.5.604 McCombe, 1987, Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases, Brain, 110, 1617, 10.1093/brain/110.6.1617 Kleyweg, 1991, Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange, J Neurol Neurosurg Psychiatry, 54, 957, 10.1136/jnnp.54.11.957 Guillain–Barre Syndrome Steroid Trial Group, 1993, Double-blind trial of intravenous methylprednisolone in Guillain–Barre syndrome, Lancet, 341, 586 Ruts, 2010, Distinguishing acute-onset CIDP from fluctuating Guillain–Barre syndrome: a prospective study, Neurology, 74, 1680, 10.1212/WNL.0b013e3181e07d14 Dionne, 2010, Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy, Muscle Nerve, 41, 202, 10.1002/mus.21480 Ryan, 2003, Paediatric mononeuritis multiplex: a report of three cases and review of the literature, Neuromuscul Disord, 13, 751, 10.1016/S0960-8966(03)00099-3 Duggins, 1999, Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy, Brain, 122, 1383, 10.1093/brain/122.7.1383 McMillan, 2010, Cranial nerve hypertrophy in pediatric chronic inflammatory demyelinating polyradiculoneuropathy, Pediatr Radiol, 40, S176, 10.1007/s00247-010-1859-4 Mazzeo, 2012, Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A, Muscle Nerve, 45, 451, 10.1002/mus.22260 Vermeulen, 1993, Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study, J Neurol Neurosurg Psychiatry, 56, 36, 10.1136/jnnp.56.1.36 Hahn, 1996, Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study, Brain, 119, 1067, 10.1093/brain/119.4.1067 Thompson, 1996, A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy, J Neurol, 243, 280, 10.1007/BF00868527 Mendell, 2001, Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy, Neurology, 56, 445, 10.1212/WNL.56.4.445 Hughes, 2008, Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial, Lancet Neurol, 7, 136, 10.1016/S1474-4422(07)70329-0 Dyck, 1994, A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 36, 838, 10.1002/ana.410360607 Hughes, 2001, Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 50, 195, 10.1002/ana.1088 Nobile-Orazio, 2012, Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial, Lancet Neurol, 11, 493, 10.1016/S1474-4422(12)70093-5 McMillan, 2011, Autoimmune neuromuscular disorders in childhood, Curr Treat Options Neurol, 13, 590, 10.1007/s11940-011-0146-5 Brannagan, 2009, Current treatments of chronic immune-mediated demyelinating polyneuropathies, Muscle Nerve, 39, 563, 10.1002/mus.21277 Grillo, 2001, Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders, Neurology, 57, 1699, 10.1212/WNL.57.9.1699 Dyck, 1982, Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment, Ann Neurol, 11, 136, 10.1002/ana.410110205 Sladky, 2008, What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?, Muscle Nerve, 38, 1638, 10.1002/mus.21058 Dyck, 1986, Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy, N Engl J Med, 314, 461, 10.1056/NEJM198602203140801 Hahn, 1996, Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study, Brain, 119, 1055, 10.1093/brain/119.4.1055 Dalakas, 1981, Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment, Ann Neurol, 9, 134, 10.1002/ana.410090719 Dyck, 1985, Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy, Neurology, 35, 1173, 10.1212/WNL.35.8.1173 Hughes, 2009, Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial, Expert Rev Neurother, 9, 789, 10.1586/ern.09.30 Gorson, 2004, Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy, Neurology, 63, 715, 10.1212/01.WNL.0000134676.05850.C0 Hughes, 2010, Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy, Neurology, 74, 651, 10.1212/WNL.0b013e3181d1a862 Gorson, 2007, Rituximab treatment in patients with IVIG-dependent immune polyneuropathy: a prospective pilot trial, Muscle Nerve, 35, 66, 10.1002/mus.20664